Enveric Biosciences Inc vs State Street SPDR Bloomberg High Yield Bond ETF — how do they compare? Enveric Biosciences Inc trades at $1.45 (market cap $6.20M), while State Street SPDR Bloomberg High Yield Bond ETF trades at $95.74. The key difference: State Street SPDR Bloomberg High Yield Bond ETF is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ENVB | JNK | |
|---|---|---|
Market Cap | $6.20M | — |
Sector | Health | Fixed Income |
52-Week High | $17.40 | $98.19 |
52-Week Low | $1.27 | $94.66 |
Enterprise Value | $1.30M | — |
Trailing returns across standard periods
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →JNK is a major ETF tracking the Bloomberg High Yield Very Liquid Index. It provides exposure to U.S. dollar-denominated junk bonds with above-average liquidity, featuring 2026 top holdings like EchoStar, Cloud Software Group, and Carnival Corp.
Read more on JNK →